CST BLOG

The official blog of Cell Signaling Technology, where we discuss what to expect from your time at the bench, share tips, tricks, and information.

CST Blog

Read More →

CiteAb Top 100: The Top-Ranked Recombinant Antibodies & Discovery Reagents

Each year, the CiteAb Top 100 Antibodies report highlights the reagents cited most frequently in pub...
Alexandra FoleyOct 31, 2025

Hallmarks of Cancer: Unlocking Phenotypic Plasticity

In 2022, an update was made to the Hallmarks of Cancer framework to expand beyond the eight hallmark...
Antony Wood, PhDOct 22, 2025

Hallmarks of Cancer: Inducing or Accessing Vasculature (Angiogenesis)

Imagine a rapidly growing city—it needs roads, plumbing, and power lines to thrive. So too, do tumor...
Susan Kane, PhDOct 8, 2025

Anything but Rabbit: Why Multiplex with Chimeric Antibodies?

It’s a refrain you’ve likely said before: “Give me anything but rabbit!” While rabbit antibodies are...
Supriya Singh, PhDOct 1, 2025

Astrocyte Activation Markers for CNS Injury & Neurodegenerative Disease Research

Astrocytes play an important role in the central nervous system (CNS), supplying nutrients to neuron...
Supriya Singh, PhDSep 24, 2025

Hallmarks of Cancer: Deregulating Cellular Metabolism

Cancer cells have a high demand for biomass—cellular components such as proteins, nucleic acids, and...
Jianxin Xie, PhDSep 17, 2025

Protect Your Drug Development Pipeline: Don't Let Antibody Supply Disrupt Your Progress

For many researchers, choosing the right antibody for a project is one of the most important parts o...
Josh NathanSep 10, 2025

ELISA Reproducibility: How CST Validates Lot-to-Lot Consistency

Over the past eight years working as a Product Scientist at CST, a big part of my role has been to t...
Emily EstabrookAug 27, 2025

Hallmarks of Cancer: Genome Instability and Mutation

Genetic alterations are a fundamental characteristic of cancer. When DNA mutations and chromosomal r...
Susan Keezer, PhDAug 20, 2025

Hallmarks of Cancer: Avoiding Immune Destruction

This blog explores the mechanisms, pathways, and proteins involved in one of the Hallmarks of Cancer...
Emily Alonzo, PhDAug 13, 2025

A Sustainable Supply Chain: Ambient Shipping & Antibody Stability at CST

Did you know that around 60% of CST antibodies are shipped at room temperature, eliminating the need...
Alexandra FoleyAug 6, 2025

Three Reasons Flow Cytometry Controls Give You CAR Confidence

Chimeric Antigen Receptor (CAR) cell therapies continue to advance, but the high cost and lengthy ti...
Andrea Tu, PhDJul 23, 2025

Automating PTM Profiling for Mass Spec: Scalable Proteomics Workflows Using PTMScan® Reagents

Studying post-translational modifications (PTMs) is critical for advancing our understanding of cell...
Barry ZeeJul 16, 2025

Mechanisms of Cell Death: Ferroptosis

What is ferroptosis? Ferroptosis is an iron-dependent form of programmed cell death with distinct mo...
Gary Kasof, PhDJul 9, 2025

Top 10 Biomarkers Powering Parkinson’s Disease Research

Parkinson’s disease (PD) is a relentless, progressive neurodegenerative disease characterized by the...
Richard Cho, PhDJun 25, 2025

Mechanisms of Cell Death: Apoptosis

What is apoptosis? Apoptosis is a form of programmed cell death (PCD) characterized by cell shrinkag...
Gary Kasof, PhDJun 18, 2025

      Categories

      MASTER - Trial Size Email Ad - Mobile (US)

      CST Newsletter

      Popular Posts

      Recent Posts
      CST blog Cellular Landscape Footer